@eduardoreyes22's TRT green screen claims, fact-checked
Quick answer
The transcript references what may be a testosterone level or dose around 160 or 300 (in either ng/dL or mg), consistent with TRT-related content, but the audio is too incoherent to extract a verifiable clinical claim. Viewers in the TRT category who encounter this content may conflate noise with medical guidance, which is a genuine information hazard. Any discussion of testosterone targets or dosing requires baseline labs, symptom assessment, and provider oversight, none of which a 6,500-view TikTok can substitute.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @eduardoreyes22 actually say?
Honestly? It's hard to tell. The transcript is largely unintelligible, a mix of fragmented English, Spanish, and phonetic noise that doesn't resolve into coherent medical claims. The clearest phrase is a reference to a "super super level" at the end, and there's something that sounds like a testosterone dosage number near "160" and "trescientos" (300). That's about all we can work with.
The creator seems to be discussing testosterone levels, possibly referencing a lab result or a dosage figure. There's a reference to "total testosterone" buried in the phonetic mess, and the hashtag category confirms this is TRT content. But without a decipherable argument, we're essentially fact-checking a Rorschach test. That's a problem for viewers trying to make real health decisions based on what they watch.
Does the science back this up?
There's nothing coherent enough here to either support or refute with literature. However, since this video sits in the TRT category and mentions numbers that could plausibly reference testosterone levels or dosages, it's worth grounding the science in what we actually know.
Normal total testosterone in adult men ranges from roughly 300 to 1000 ng/dL, according to the American Urological Association's 2018 guidelines. Hypogonadism is clinically defined as consistently below 300 ng/dL combined with symptoms. Saad et al. (2011, Journal of Sexual Medicine) found that TRT in genuinely hypogonadal men improved energy, mood, and libido over 12 months. But "optimization" in otherwise healthy men is a grayer area. A 2023 NEJM trial by Lincoff et al. found TRT was non-inferior to placebo for cardiovascular events in men with hypogonadism, which is reassuring, but the study wasn't designed to validate hormone optimization in men with normal levels.
What did they get wrong (or right)?
We can't credit or fault the creator for specific medical claims because no specific medical claim was coherently made. What we can say is this: if the video intended to communicate something meaningful about testosterone targets or dosing, it failed completely. Viewers got noise, not information.
If the number "160" refers to a testosterone level in ng/dL, that would genuinely be low and could support a TRT conversation with a physician. If it refers to a milligram dose of testosterone cypionate, that's on the higher end of typical starting doses (50 to 100 mg weekly is common in clinical practice) and would need context that simply isn't here. Bhasin et al. (2010, NEJM) showed dose-dependent effects of testosterone, meaning the number matters enormously and should never be thrown out without context. Doing so, even accidentally through incoherence, is irresponsible.
What should you actually know?
TRT is a legitimate, well-studied treatment for hypogonadism. It is not a performance hack to be self-prescribed based on a TikTok video you can barely understand. Here's what the evidence actually says.
- Diagnosis requires two morning total testosterone draws below 300 ng/dL plus clinical symptoms, per Endocrine Society guidelines (Bhasin et al., 2010).
- Formulation matters. Gels, injections, and pellets have different absorption profiles and side effect patterns. They are not interchangeable without clinical judgment.
- Hematocrit elevation is a real risk. TRT increases red blood cell production, and unchecked, that raises clotting risk. Regular monitoring is not optional.
- Fertility suppression is near-certain on TRT. The hypothalamic-pituitary axis shuts down endogenous production, which means sperm counts drop, often significantly.
- "Super levels" are not a goal. Supraphysiologic testosterone is associated with increased cardiovascular strain and is outside the scope of legitimate TRT as defined by any major medical society.
The bottom line
This video should not inform any health decision. The content is indecipherable, the claims are unextractable, and the format, a green screen TikTok with no clear sourcing, is not a substitute for a clinical evaluation. If you're curious about your testosterone levels, get a blood panel ordered by a licensed provider. FormBlends and similar regulated telehealth platforms exist precisely because the alternative is taking medical cues from videos like this one.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @eduardoreyes22's TRT green screen claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@eduardoreyes22's TRT green screen claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The transcript references what may be a testosterone level or dose around 160 or 300 (in either ng/dL or mg), consistent with TRT-related content, but the audio is too incoherent to extract a verifiable clinical claim.
FormBlends verdict
The transcript references what may be a testosterone level or dose around 160 or 300 (in either ng/dL or mg), consistent with TRT-related content, but the audio is too incoherent to extract a verifiable clinical claim. Viewers in the TRT category who encounter this content may conflate noise with medical guidance, which is a genuine information hazard. Any discussion of testosterone targets or dosing requires baseline labs, symptom assessment, and provider oversight, none of which a 6,500-view TikTok can substitute.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The transcript references what may be a testosterone level or dose around 160 or 300 (in either ng/dL or mg), consistent with TRT-related content, but the audio is too incoherent to extract a verifiable clinical claim. Viewers in the TRT category who encounter this content may conflate noise with medical guidance, which is a genuine information hazard. Any discussion of testosterone targets or dosing requires baseline labs, symptom assessment, and provider oversight, none of which a 6,500-view TikTok can substitute.
- The AUA and Endocrine Society define hypogonadism as two morning total testosterone readings consistently below 300 ng/dL combined with symptoms, not a single number from a TikTok.
- Lincoff et al. (2023, NEJM) found TRT was cardiovascularly non-inferior to placebo in hypogonadal men, but the study did not validate supraphysiologic 'optimization' in healthy men.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The AUA and Endocrine Society define hypogonadism as two morning total testosterone readings consistently below 300 ng/dL combined with symptoms, not a single number from a TikTok.
- Lincoff et al. (2023, NEJM) found TRT was cardiovascularly non-inferior to placebo in hypogonadal men, but the study did not validate supraphysiologic 'optimization' in healthy men.
- Bhasin et al. (2010, NEJM) demonstrated that testosterone has dose-dependent effects on muscle, fat, and sexual function, meaning dosing context is not optional information.
- TRT reliably suppresses endogenous testosterone production via the hypothalamic-pituitary axis, reducing sperm counts significantly in most men within weeks of starting.
- Hematocrit must be monitored on TRT. Elevated red blood cell mass increases clotting risk, and this is one of the primary reasons TRT requires ongoing lab oversight.
- No coherent, fact-checkable medical claim could be extracted from this video. Viewers should not use it to inform any decision about testosterone therapy.
- Regulated telehealth platforms require baseline labs and clinician review before initiating TRT, a standard that exists because self-directed hormone use based on social media content carries real clinical risk.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Eduardo Reyes · TikTok creator
6.5K views on this video
#greenscreen
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Eduardo Reyes, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.